Skip to content Skip to main navigation Skip to footer

The International Journal of Oral & Maxillofacial Implants

Edited by Steven E. Eckert, DDS, MS

This highly regarded, frequently cited journal integrates clinical and scientific data to improve methods and results of oral and maxillofacial implant therapy, compiles research, technology, clinical applications, reviews of the literature, and new developments in reconstructive dentistry and implant techniques. Regular features include “Current Issues Forum,” which presents opinions of invited experts on controversial issues, and “Literature Review,” which keeps readers informed about implant-related publications.

 

To read abstracts for each article, click on the titles below.

Table of Contents - Volume 37, No. 5, 2022

Clark M. Stanford, DDS, PhD, MHA

In the writing, review, and editorial processes we each undertake, we seek clarity through shortening sentences and crafting short narratives using figures or pictures to get to the heart of what we are trying to convey. Inadvertently, this process of compacting significance into a brief choice of a word, phrase, or abbreviation can lead to significant confusion. Confusion can occur from cultural meaning, context, or the forum in which the construct is used, as well as our biases and assumptions. It is well accepted in scientific writing that the author should always define the full term before using an abbreviation. This creates the context in which the reader then understands the abbreviation later in the article. In turn, abbreviations can become so commonly used within a discipline that it is rather assumed one already knows the meaning. To explain it to a reader somehow conveys that they are out of date for not knowing. The reality is that abbreviations can be useful when a small team completely understands this form of communication (say, in a blue code situation in a hospital operating room, or in an airplane cockpit trying to talk with an air traffic controller). Clear understanding can avoid confusion and may even save a life.

In the process of scientific publishing, more databases are scraping journal citations and data searching on the abstracts of articles. Since the database is not searching the whole article, the meaning of an abbreviation is not clear if it was used in the abstract without definition. Therefore, journals like JOMI have a policy to not allow abbreviations in the abstract. The irony here is that an abstract is already an “abbreviation” for the full paper itself. Where this gets tricky is when abbreviations are used for various measurements the authors have used. Not only can abbreviations like MBL be confusing, but some articles will also use abbreviation extensions almost to the point of suspected obfuscation. There is nothing more frustrating than to have a sentence such as the following: “When MBL levels were measured at time BMBL to time 1MBL, 2MBL, and 3BML, it is clear HBMBL and VBMBL at each time period referenced respective, BMBL.” “Huh” is my typically confused response. That the author measures baseline marginal bone levels in a horizontal (H) and vertical (V) manner at three time periods (1, 2, 3) following placement may be a reasonable experimental design, but a table format could explain this without multiple chains of abbreviations. As a colleague once said to me, “If only I had more time, I would have written a shorter paper.”

Now to the heart of the problem. What do we mean by MBL? It could be marginal bone levels, median marginal bone levels, mean marginal bone loss, median marginal bone loss, etc. Marginal bone level implies that an author is measuring the apparent position of mesial and/or distal radiographic bone levels at a point in time. It is up to the reader to determine the significance since marginal bone level could easily be at the apex of the implant. On the other hand, marginal bone loss implies that there is a reference point used to measure from that is clear on a radiograph. Further, bone loss implies a net change at a specific time point, not just a linear measure. The way the data are now reported becomes a challenge. Data can be presented as descriptive linear changes or percentages relative to some time point (preferably implant placement). One could state marginal bone loss from implant placement, restoration, or between time points in the study (hopefully with a consistent sample size and measurement of the same implant/subject). Well, enough of this rabbit hole.

The challenge with the implant literature is that we have tried to bring editorial standards to bear to support the authors and readers. Yet, the standards are often ignored in the spirit of individualism and uniqueness. An editor is needed to return the paper to the author and seek ongoing clarification and alignment with the standards of the journal. The other issue with abbreviations is the need to always be careful and judicious in their use. Take, for instance, the use of the term “MBL.” For some, MBL means Major League Baseball, while for others, it means Marine Biological Laboratory, and yet for others, it means monoclonal B-cell lymphocytosis, etc, in addition to the various permutations I’ve already mentioned. If one is not careful, you could even think this is about a certain Saudi prince’s name. The point is, we need clarity and standards in the use of any abbreviations and acronyms. These are all important forms of shorthand that we use on a daily basis, but it may be worth stopping from time to time and asking, “am I making sense?” As Alan Greenspan (a prior U.S. Federal Reserve Chair) said, “I know you think you understand what you thought I said, but I’m not sure you realize that what you heard is not what I meant.”

Yes, clarity and brevity save paper, mental bandwidth, and perhaps even lives. That is, if everyone understands what you meant.

Thank you.
Clark M. Stanford, DDS, PhD, MHA
Editor-in-Chief

Cho-Ying Lin, DDS/Zhaozhao Chen, DDS, MS, PhD/Hong-Lin Chiang, DDS/Whei-Lin Pan, DDS/Hom-Lay Wang, DDS, MS, PhD

Purpose: To investigate the impact of implantoplasty (IP) with or without regenerative procedures on treatment outcomes of peri-implantitis.

Materials and Methods: Electronic and manual literature searches were conducted for clinical trials published up to October 2020 that evaluated clinical outcomes (at least 6-month follow-up) after peri-implantitis treatment involving IP. The implant survival rate and clinical parameters (eg, probing depth [PD], bleeding on probing [BOP], marginal bone loss [MBL], clinical attachment level [CAL], and mucosal recession [REC]) at baseline and follow-ups were extracted from original articles for qualitative analyses. Risk ratio and weighted mean difference with 95% CI were calculated using a random-effects model.

Results: Out of 322 studies, 17 (9 randomized controlled trials, 4 controlled clinical trials, and 4 case series) were included in the present study. The regeneration group presented a 97% (95% CI: 0.95 to 1.00) implant survival rate, and the nonregeneration group showed a 94% (95% CI: 0.90 to 0.98) survival rate. Both groups revealed similar outcomes in PD and BOP reductions and soft tissue REC. However, the regeneration group had more favorable results in MBL.

Conclusion: Data from this study suggested that applying implantoplasty during a regeneration or nonregeneration surgical approach resulted in a high implant survival rate and peri-implantitis resolution. Although no differences were found in the majority of clinical parameters in both groups, the regenerative approach resulted in more radiographic bone fill than the nonregenerative treatment.

DOI: 10.11607/jomi.9436

Qian-Hui Shi, MDS/Yi Luo, MDS/Yu-Ting Cheng, DDS/Hua Huo, MDS/Chao Wu, MDS/Jian Liao, PhD, DDS, Prof

Purpose: To assess the effect of nongrafted and grafted materials on transalveolar sinus floor elevation (TSFE) with implant placement.

Materials and Methods: Relevant studies published between January 1, 1994, and July 31, 2021, were selected by searching Embase, PubMed/MEDLINE, Web of Science, and Cochrane Central Register of Controlled Trials. The study subjects were restricted to humans, and the language was limited to English. The study was confined to randomized controlled trials, controlled clinical trials, and observational studies (prospective and retrospective cohort) related to TSFE with and without bone-grafting materials. Two reviewers independently extracted study data and conducted quality assessments according to the Cochrane handbook and NOS scale. RevMan 5.3 and Stata 15.1 software were then used to analyze the research data that met the inclusion criteria.

Results: A total of nine articles were included, including 421 implants in the graft group and 502 implants in the nongraft group. Meta-analysis showed that there was no significant difference in the implant failure rate (RR = 1.03, 95% CI: 1.00, 1.06, P = .08) or marginal bone loss (SMD = 0.06, 95% CI: –0.23, –0.35, P = .69) between implants with and without graft materials after TSFE. The amount of endosinus bone gain in the nongraft group was significantly lower than that in the graft group (SMD = –1.07, 95% CI: –1.73: –0.41, P = .0001).

Conclusion: TSFE in implants with or without grafting can achieve similar results, but there may be more bone gain in TSFE with grafting.

DOI: 10.11607/jomi.9758

Bahar Sayin, DDS, MS/Haydar Albayrak, DDS, PhD/Zekeriya Tasdemir, DDS, PhD/Neslihan Sungur, MD

Purpose: To observe the effect of different prosthetic materials (polymethyl methacrylate [PMMA] and flowable composite [FC]) on marginal bone loss, pink esthetic score (PES), and cytokine levels (receptor activator of nuclear factor kappa-Β ligand [RANKL] and osteoprotegerin [OPG]).

Materials and Methods: A total of 46 patients (31 women, 15 men) were treated with immediate implant therapy after tooth extraction. For standardization, only the maxillary premolar tooth of each patient was restored, and also, both of the adjacent teeth were present in the dental arch. Provisional crowns were prepared before the surgery on patient models with two different materials (24 PMMA, 22 FC). Following the surgical procedure, provisional crowns were adjusted on polyetheretherketone (PEEK) abutments as nonfunctional in centric and eccentric movements. After the surgery, patients were evaluated monthly for 3 months. At each follow-up, periapical radiography was obtained by the parallel technique, and peri-implant crevicular fluid (PICF) was collected. Pink esthetic scoring was done. MBL was calculated for the mesial and distal sides separately. Cytokine levels were analyzed from PICF. Statistical analyses (Shapiro-Wilk, Mann-Whitney U, independent-samples t test, Wilcoxon t test, paired-samples t test, and Friedman two-way analysis of variance with Bonferroni correction) were completed (α = .05).

Results: PES was increased significantly within groups (P < .01). However, there was no statistically significant difference between groups. According to the Mann-Whitney U test, no significant difference was found for the MBL (P > .05). When the RANKL/OPG values were evaluated within the group by using the Friedmann two-way analysis of variance test, no significant difference was found (P > .05).

Conclusion: Similar pink esthetics, cytokine levels, and bone loss can be achieved using a protocol including immediate implants, particle grafts, soft tissue graft, PEEK abutments, and provisional restorations fabricated using PMMA and FC.

DOI: 10.11607/jomi.9439

Qian-Hui Shi, MDS/Yi Luo, MDS/Yu-Ting Cheng, DDS/Hua Huo, MDS/Chao Wu, MDS/Jian Liao, PhD, DDS, Prof

Purpose: To assess the effect of nongrafted and grafted materials on transalveolar sinus floor elevation (TSFE) with implant placement.

Materials and Methods: Relevant studies published between January 1, 1994, and July 31, 2021, were selected by searching Embase, PubMed/MEDLINE, Web of Science, and Cochrane Central Register of Controlled Trials. The study subjects were restricted to humans, and the language was limited to English. The study was confined to randomized controlled trials, controlled clinical trials, and observational studies (prospective and retrospective cohort) related to TSFE with and without bone-grafting materials. Two reviewers independently extracted study data and conducted quality assessments according to the Cochrane handbook and NOS scale. RevMan 5.3 and Stata 15.1 software were then used to analyze the research data that met the inclusion criteria.

Results: A total of nine articles were included, including 421 implants in the graft group and 502 implants in the nongraft group. Meta-analysis showed that there was no significant difference in the implant failure rate (RR = 1.03, 95% CI: 1.00, 1.06, P = .08) or marginal bone loss (SMD = 0.06, 95% CI: –0.23, –0.35, P = .69) between implants with and without graft materials after TSFE. The amount of endosinus bone gain in the nongraft group was significantly lower than that in the graft group (SMD = –1.07, 95% CI: –1.73: –0.41, P = .0001).

Conclusion: TSFE in implants with or without grafting can achieve similar results, but there may be more bone gain in TSFE with grafting.

DOI: 10.11607/jomi.9758

Lixuan Niu, MD/Huajie Yu, MD/Juan Wang, MD/Yiman Tang, MD/Lixin Qiu, MD, PhD

Purpose: To identify the impact of residual bone height on 5-year implant survival and prosthetic complication rates in patients who underwent maxillary sinus grafting.

Materials and Methods: A total of 87 consecutive patients were treated with 104 lateral approach maxillary sinus floor augmentation procedures with 100% deproteinized bovine bone and received 169 implants. The analysis considered patient age, sex, time of implant placement, and residual bone height. Patients with < 3 mm residual bone height were assigned to the study group; otherwise, they were placed in the control group. Results: The mean follow-up was 68.2 months (0 to 103 months). The mean residual bone height was 1.8 mm in the study group and 4.1 mm in the control group. The 5-year implant survival and prosthetic complication rates were, respectively, 97.4% and 8.0% in the study group and 100% and 12.5% in the control group. Residual bone height, sex, age, and time of implant placement were not significant factors for the 5-year implant survival or prosthetic complication rate. The lateral bone wall was significantly thinner in the study group. The grafted bone height reduction was significantly different at 6 months and 2 years postoperation in both groups, but there was no difference in the change in grafted bone height reduction over time between the two groups.

Conclusion: A residual bone height < 3 mm did not impact the survival rates of implants placed in grafted maxillary sinuses or the prosthetic complication rate after 5 years of functional loading. DOI: 10.11607/jomi.9453

Yifat Manor, DMD/Ilan Beitlitum, DMD/Alex Manor, MPH/Ronit Bar-Ness Greenshtein, PhD

Purpose: To investigate the effects of periopathogens on bone grafts for maxillary sinus floor augmentation and implant survival.

Materials and Methods: A cohort study was designed. Samples from maxillary sinus floor augmentation sites and from periodontal pockets in adjacent teeth of the same patients were collected during the surgery and following periodontal maintenance and plaque removal. Polymerase chain reaction (PCR) was performed by an external lab service for analysis of the following periopathogens: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, and Treponema denticola. Correlations between the presence of periopathogens in sinus sites and periodontal pockets in adjacent teeth and the clinical findings (bone and implant survival) were studied.

Results: A total of 23 patients were suitable for study inclusion. Periopathogens were found in sinus sites in 6 patients (26%) and in tooth sites in 15 patients (65%). There was low correlation for the presence of periopathogens between tooth sites and sinus sites and for complications.

Conclusion: The presence of periopathogens as revealed by PCR was lower in sinus sites compared with tooth sites. Their presence neither caused bone pathology nor affected dental implant survival. The presence of periopathogens in sinus sites is inevitable even under periodontal maintenance. Although its presence did not endanger implant survival, future studies are recommended for studying this issue. Further analyses of the presence of periopathogens in cases of bone resorption at the apex of dental implants inserted into sites of augmented sinuses are warranted.

DOI: 10.11607/jomi.9576

Giovanni-Battista Menchini-Fabris, DDS/Paolo Toti, BSc, DDS/Ugo Covani, MD, DDS/Giovanni Crespi, DDS/Bruno Carlo Brevi, MD/Roberto Crespi, MD, MSc

Purpose: To examine the short-term outcomes of maxillary sinus augmentations consisting of laterally and apically displacing the palatal wall through a transcrestal approach.

Materials and Methods: The maxillary sinus floor was fractured in its palatal aspect by allowing a displacement in the buccal and apical direction with a magnetoelectric system. A medial displacement of the alveolar crest in its palatal bony plate was performed at the same time. Crestal bone change was investigated using superimposed preoperative and postsurgical computed tomography scans. Clinical and radiologic outcomes over 1 year were evaluated.

Results: A total of 18 implants were selected for retrospective volumetric and linear analyses. Sinus floor and alveolar bone augmentation surgery led to a significant increase in the bone volume (P = .0002) from 0.134 ± 0.060 cm3 to 0.639 ± 0.166 cm3, with an overall gain of +0.504 ± 0.139 cm3. No part of the implant apices appeared to protrude into the maxillary sinus at the 1-year follow-up. The width of the alveolar crest changed from 5.1 ± 0.5 mm to 6.5 ± 0.7 mm, with a significant increase of +1.4 ± 0.6 mm registered at 1 year. However, a marginal bone loss of 1.0 ± 0.8 mm was observed. When tooth positions were investigated, no significant differences between the two groups (premolars versus molars) were found.

Conclusion: Significant and effective bone gains allowed proper placement of the dental implants but with a minimal loss of peri-implant bone volume.

DOI: 10.11607/jomi.9594

Marcelo Parra, DDS, PhD/Ernesto B. Benalcázar Jalkh, DDS, MSci, PhD/Nick Tovar, PhD, DDS/Andrea Torroni, MD, PhD/Rafael M. Badalov/Estevam A. Bonfante, DDS, PhD/Vasudev Nayak, MSci/Arthur Castellano, DDS/Paulo G. Coelho, MD, DDS, PhD, MBA/Lukasz Witek, MSci, PhD

Purpose: To qualitatively and quantitatively evaluate histologic osseointegration parameters of implants designed with decompressing vertical chambers between the threads with two different surface treatments (TiO2 blasting + maleic acid vs TiO2 blasting + maleic + HCl) in a large translational animal model at 3 and 6 weeks in vivo.

Materials and Methods: Nine female sheep were used, and 72 implants with trapezoidal threads and decompressing vertical chambers of 0.6 mm in diameter and 0.2 mm in depth were placed in the ilium crest. After 3 and 6 weeks, the animals were euthanized, and biomechanical and histomophometric analyses were performed.

Results: Survey histologic evaluation indicated intimate contact between the bone and the implants independent of surface treatment at both times in vivo. Bone formation at both time points depicted an intramembranous-type healing pattern between the implant threads. The mean removal torque values for all groups showed a relative increase in removal torque from 3 to 6 weeks. In terms of bone area fraction occupancy analysis, significant differences were found at 6 weeks between surface treatments (P = .046), where the experimental surface yielded higher degrees of bone area fraction occupancy.

Conclusion: Conical implants with decompressing vertical chambers between threads presented similar osseointegration parameters regarding bone-toimplant contact and torque-out test values irrespective of surface treatment. However, shifting from a minimally rough to a moderately rough surface (experimental surface with supplemental acid-etching) resulted in significantly improved bone area fraction occupancy at 6 weeks.

DOI: 10.11607/jomi.9354

Sergey S. Edranov, MD/Sergei G. Kalinichenko, MD/Natalya Yu. Matveeva, MD

Purpose: To study the distribution of markers of mesenchymal stem cells (clusters of differentiation-29 and -44), osteoblasts (osteocalcin), and transforming growth factor-β1 in the mandibular tissue of miniature pigs after on-bone fixation of a free gingival graft.

Materials and Methods: Six outbred male miniature pigs 2 years of age were used in the study. In the external surface of the mandible, the periosteum was excised from all over the free gingival graft fixation area. A free gingival graft was placed on the wound and fixed. In control animals, instead of free gingival graft, a piece of mucoderm (porcine accellular dermal matrix, Botiss Biomaterials) was placed on the wound and fixed. Three months after the surgery, a portion of bone tissue was sampled from the free gingival graft insertion area. The samples were immunohistochemically stained using antibodies against osteoblast and mesenchymal stem cell markers.

Results: Three months after surgery, high expression levels of the aforementioned markers were detected in the contact zone between the graft and alveolar bone. Clusters of differentiation-29– and -44–immunopositive cells predominated at the border of the new bone tissue and gingival lamina propria as well as in Haversian canals. Osteocalcin-positive cells were observed mainly in the layer of outer circumferential lamellae, on the surface of concentric lamellae of young osteons forming Haversian canals, and in the Haversian canals in the immediate vicinity of the graft. The bulk of transforming growth factor-β1–expressing cells occurred in the connective tissue Volkmann and Haversian canals and the adventitious and inner vascular membranes.

Conclusion: On-bone free gingival graft fixation results in remodeling of the alveolar bone and is accompanied by a change in the immunoreactivity against factors controlling osteogenic differentiation. Clusters of differentiation-29 and -44 expression in mandibular bone tissues suggest that free gingival graft placement results in activation of mesenchymal stem cells and their transforming growth factor-β1–mediated differentiation into osteocalcin-containing osteoblasts.

DOI: 10.11607/jomi.9456

Dilek Bahar, PhD/Zeynep Burcin Gonen, DDS, PhD/Menemse Gumusderelioglu, PhD/Mehmet Emin Onger, MD, PhD/Elvan Konuk Tokak, MSc/Fatma Ozturk-Kup, PhD/Buket Banu Ozkan, McS/Nur Seda Gokdemir, MSc/Mustafa Cetin, MD

Purpose: To seek out the bone regeneration effect of human umbilical cord–mesenchymal stem cell (hUC-MSC)–derived exosomes of loaded chitosan/hydroxyapatite (CS/HA) scaffold in a rat calvarium bone regeneration model.

Materials and Methods: The hUC-MSC exosomes were purified and characterized. The scaffolds were prepared by a freeze-drying method. Animals were divided into five groups, and the CS/HA/exosome (CS/HA/Exo) scaffolds were transplanted to 5 × 2-mm critical-sized calvarial bone defects for repair in rats. All animals were sacrificed at the postoperative sixth week. Immunohistochemical and histologic analyses were performed.

Results: Scanning electron microscopy (SEM) images showed that the exosomes were round-shaped vesicles with bounded membrane, and the diameter of the exosomes was 83.728 ± 27.269 nm. Histologic analysis showed that mean new bone volumes were statistically significantly higher in the CS/HA/Exo group (1.83 ± 0.54, PCS/Exo-CS/HA/Exo = .000), and other new bone volumes in the other groups were statistically significant compared with the control (CS/Exo 1.50 ± 0.14 mm3; CS 1.20 ± 0.43 mm3; control 1.06 ± 0.10 mm3; and CS/HA 1.43 ± 0.66 mm3).

Conclusion: The CS/HA/Exo combination is a novel treatment for bone defect repair to induce bone formation. The CS scaffold can significantly promote bone regeneration compared with the control. Moreover, the combination with HA and exosomes is promising for applications in bone tissue regeneration.

DOI: 10.11607/jomi.9515

Amit M. Gaikwad, BDS, MDS/Amruta A. Joshi, BDS, MDS/Seema Yadav, BDS, MDS/Jyoti B. Nadgere, BDS, MDS

Purpose: To evaluate whether the placement of endosseous dental implants along with intentionally retained root fragments enhances peri-implant histologic characteristics and outcomes in healthy animal models.

Materials and Methods: Two review authors independently performed electronic literature searches across the PubMed/MEDLINE, LILACS, EBSCOhost, and Science Direct databases by using different keywords and Medical Subject Headings terms to identify relevant articles. Only preclinical animal trials evaluating the histology of peri-implant tissues around endosseous dental implants placed along with intentionally retained root fragments were included in the review. The risk of bias assessment was investigated using the Systematic Review Centre for Laboratory animal Experimentation (SYRCLE) tool, and the reporting quality of each trial was evaluated using the Animal Research: Reporting in Vivo Experiments guidelines.

Results: Seven preclinical trials including a total of 33 animals and 155 endosseous dental implants were eligible for the analysis. One trial reported the histologic assessment of peri-implant tissues around endosseous dental implants with ankylotic root fragments, whereas the other six studies used nonankylotic root fragments. The effects of the length of retained root fragments on peri-implant tissues were reported in two trials that showed contrasting results. The effects of the width of retained root fragments were assessed in two trials reporting that a remaining thickness < 2 mm and buccal bone thickness > 3 mm favors alveolar bone preservation over a period of 12 weeks. Although the mean quality assessment score for all preclinical trials was moderately high, the summary for the risk of bias presented a high risk.

Conclusion: Limited data and short-term preclinical evidence showed optimal peri-implant histologic findings of endosseous dental implants placed along with intentionally retained root fragments. However, further preclinical histologic evaluation with homogenous populations and long-term controlled clinical studies are needed to substantiate its applicability in clinical situations.

DOI: 10.11607/jomi.9494

Ofer Moses, MDM/Franco Bengazi, MD, PhD/Mauro Ferri, DDS/Francesco Gianfreda, DDS/Joaquin Urbizo Velez, DDS, PhD/Daniele Botticelli, MD, PhD/Luigi Canullo, DDS, PhD

Purpose: To monitor the early bone reaction in a canine model to a conventional sandblasted and dual acid-etched implant surface (ABT), a nanostructured hydrophilic surface (Nano), a dry salt–bioactivated ultra-hydrophilic surface (Hydro), and a bioactivated nanosurface obtained from the addition of dry salts to the Nano surface (Nano-Active).

Materials and Methods: ABT, Nano, Hydro, and Nano-Active implants were placed in 12 dogs. A randomized split-mouth design was adopted. One implant of each type was placed in the mandible 3 months after tooth extraction in healed sites at the first molar region bilaterally. In the same session, the third and fourth premolars were extracted bilaterally and one implant of each type was immediately placed into the extraction socket. The dogs were euthanized at 14 and 28 days following surgery, and the peri-implant bone reaction was assessed histologically using Stevenel’s blue and alizarin red in nondecalcified sections.

Results: The postoperative healing was uneventful. The 14-day histologic analysis reported nonsignificant results in terms of difference between the groups, while significant results were found 28 days after surgery. In fact, a significantly higher rate of new bone around the implant was reported in the Nano-Active compared to the Nano groups (51.0% ± 10.2% vs 36.0% ± 10.2%) and Hydro compared to the Nano groups (47.3% ± 10.7% vs 36.0% ± 10.2%).

Conclusion: The results obtained indicate that new bone formed after 4 weeks demonstrated a tendency for dry salt–treated bioactivated surfaces to improve bone deposition in the interface in the early stages of healing; however, due to the limited number of dogs, the results failed to show a statistical significance. A study with a significantly larger group of animals should be performed in order to challenge the assumption that ultra-hydrophilic–surface implants might show higher bone-implant contact in immediate postextraction replacement.

DOI: 10.11607/jomi.9581

AO MEMBERS – sign in for full access to the most current issue and all archived issues of JOMI

JOMI & IJPRD Spotlight Feature Articles

Back to top